Gamma surgery in the treatment of nonsecretory pituitary macroadenoma

被引:102
|
作者
Mingione, Vincenzo [1 ]
Yen, Chun Po [1 ]
Vance, Mary Lee [1 ]
Steiner, Melita [1 ]
Sheehan, Jason [1 ]
Laws, Edward R. [1 ]
Steiner, Ladislau [1 ]
机构
[1] Univ Virginia, Dept Neurol Surg, Lars Leksell Ctr Gamma Surg, Hlth Syst, Charlottesville, VA 22908 USA
关键词
nonsecretory pituitary macroadenoma; hypopituitarism; gamma knife; gamma surgery; transsphenoidal surgery;
D O I
10.3171/jns.2006.104.6.876
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Object. The authors report on a retrospective analysis of the imaging and clinical outcomes following gamma surgery in 100 patients with nonsecretory pituitary macroadenoma. Methods. Between June 1989 and March 2004, 100 consecutive patients with nonsecretory pituitary macroadenoma were treated at the Lars Leksell Center for Gamma Surgery, University of Virginia Health System (Charlottesville, VA). Ninety-two patients had residual or recurrent macroadenoma following one or more surgical procedures. In eight patients, gamma surgery was the primary treatment. Ten patients received conventional fractionated radiotherapy before the gamma surgery. Sixty-nine patients required hormone replacement therapy for one or more deficits before gamma knife treatment. Peripheral doses between 5 and 25 Gy (mean 18.5 Gy) were administered. Imaging and endocrinological follow-up evaluations were performed in 90 patients; these studies ranged from 6 to 142 months (mean 44.9 months) and 6 to 127 months (mean 47.9 months), respectively. Tumor volume decreased in 59 patients (65.6%), remained unchanged in 24 (26.7%), and increased in seven (7.8%). The minimal effective peripheral dose was 12 Gy; peripheral doses greater than 20 Gy did not seem to provide additional benefit. Of 61 patients with a partially or fully functioning pituitary gland and follow-up data, 12 (19.7%) suffered new hormone deficits following gamma surgery. In patients with endocrinological follow-up data that had been collected over more than 2 years, the rate of new deficits was 25%. No neurological morbidity or death was related to treatment. Conclusions. Current experience suggests that gamma surgery is an appropriate means of managing recurrent or residual nonsecretory pituitary macroadenoma following microsurgery and a primary treatment in selected patients. To evaluate definite rates of recurrence and new endocrine deficiencies, long-term follow-up studies are needed.
引用
收藏
页码:876 / 883
页数:8
相关论文
共 50 条
  • [31] Outcome of partially irradiated recurrent nonfunctioning pituitary macroadenoma by gamma knife radiosurgery
    Shen, Chiung-Chyi
    You, Weir-Chiang
    Sun, Ming-Hsi
    Lee, Shinh-Dung
    Tsou, Hsi-Kai
    Chen, Yen-Ju
    Sheu, Meei-Ling
    Sheehan, Jason
    Pan, Hung-Chuan
    JOURNAL OF NEURO-ONCOLOGY, 2018, 139 (03) : 767 - 775
  • [32] Outcome of partially irradiated recurrent nonfunctioning pituitary macroadenoma by gamma knife radiosurgery
    Chiung-Chyi Shen
    Weir-Chiang You
    Ming-Hsi Sun
    Shinh-Dung Lee
    Hsi-Kai Tsou
    Yen-Ju Chen
    Meei-Ling Sheu
    Jason Sheehan
    Hung-Chuan Pan
    Journal of Neuro-Oncology, 2018, 139 : 767 - 775
  • [34] Curative effects of head γ-SRT for the treatment of functional pituitary macroadenoma
    Lian, Wei
    Wang, Ren Zhi
    Xing, Bing
    Yao, Yong
    ONCOLOGY LETTERS, 2016, 12 (02) : 893 - 896
  • [35] Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma
    Dekkers, O. M.
    van der Klaauw, A. A.
    Pereira, A. M.
    Biermasz, N. R.
    Honkoop, P. J.
    Roelfsema, F.
    Smit, J. W. A.
    Romijn, J. A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (09): : 3364 - 3369
  • [36] Acute pituitary apoplexy complicating a pituitary macroadenoma
    Joseph, Febin
    Lockhat, Zarina I.
    Van Rensburg, Malan Janse
    Smal, Janet
    Moja, Tshepo Peter
    SA JOURNAL OF RADIOLOGY, 2010, 14 (04): : 118 - 121
  • [37] Nonfunctioning pituitary macroadenoma Response
    Heller, Robert S.
    Anderson, Emily
    Lechan, Ronald M.
    Heilman, Carl B.
    NEUROSURGICAL FOCUS, 2018, 45 (06)
  • [38] INTERESTING PRESENTATION OF PITUITARY MACROADENOMA
    Lewis, M. B.
    Patel, P.
    Duckworth, S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (02) : 479 - 479
  • [39] Pituitary macroadenoma due to hypothyroidism
    Eklioglu, Beray Selver
    Atabek, Mehmet Emre
    Akyurek, Nesibe
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2013, 26 (3-4): : 211 - 212
  • [40] A pituitary macroadenoma presenting with hyponatraemia
    Dave, J. A.
    Varkel, L.
    Semple, P.
    Levitt, N. S.
    JOURNAL OF ENDOCRINOLOGY METABOLISM AND DIABETES OF SOUTH AFRICA, 2007, 12 (02) : 74 - 76